Adverse effects · participants (any age) with a clinical diagnosis of ASD who have displayed one or more unwanted or challenging behaviours at baseline…
Antidepressants may leads to higher adverse effects compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
Antidepressants probably leads to higher number of dropouts due to adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
Antidepressants may leads to higher number of dropouts due to adverse effects compared with benzodiazepines (low certainty).
1 finding from 1 review
Adverse effects (dropouts) · patients with major depression
Antidepressants plus benzodiazepines probably leads to lower adverse effects (dropouts) compared with antidepressants alone (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · somatoform disorders in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · adults with panic disorder
Tricyclic antidepressants probably leads to higher number of dropouts due to adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · somatoform disorders in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (drop‐outs due to adverse effects4) · somatoform disorders in adults
Tricyclic antidepressants showed no clear difference in adverse effects (drop‐outs due to adverse effects4) compared with another medication (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · somatoform disorders in adults
New‐generation antidepressants showed no clear difference in adverse effects (drop‐outs due to adverse effects) compared with placebo (low certainty).
1 finding from 1 review
Adverse effects · people with epilepsy and depression
1 finding from 1 review
Adverse effects · people with epilepsy and depression
1 finding from 1 review
Adverse effects · people with epilepsy and depression
1 finding from 1 review
Intervention not reported
Adverse effects · people with epilepsy and depression
1 finding from 1 review
no estimate extracted
88 participants
Low
Adverse effects · people with epilepsy and depression
1 finding from 1 review
Adverse effects ‐ adverse event profile · people with epilepsy and depression
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
Selective serotonin reuptake inhibitors probably leads to higher number of dropouts due to adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
Serotonin‐norepinephrine reuptake inhibitors showed no clear difference in number of dropouts due to adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
TCAs may leads to higher number of dropouts due to adverse effects compared with benzodiazepines (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
It is very uncertain whether SSRIs changes number of dropouts due to adverse effects compared with benzodiazepines (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
TCAs showed no clear difference in number of dropouts due to adverse effects compared with SSRI (low certainty).
1 finding from 1 review